News

FDA approves everolimus for tuberous sclerosis-associated seizures, a treatment first discovered at Texas Children’s Hospital

04/20/2018

On April 10, 2018, the Food and Drug Administration (FDA) approved everolimus tablets for oral suspension (brand name: Afinitor Dispersz, Novartis Pharmaceuticals Corporation) as an adjunctive therapy to treat partial-onset refractory seizures in adults and children over 2 years of age with Tuber

More

Former British Prime Minister shares the lessons he learnt from his son's rare epileptic syndrome

03/02/2018

David Cameron’s son Ivan was born with a neurological disorder that baffled doctors. He was later diagnosed with Ohtahara syndromea, rare epileptic syndrome. Now, he writes, genomic testing can end the anguish of uncertainty.

More

Dr. Wu Chen wins the 2017 American Epilepsy Society's Young Investigator Award

09/08/2017

Dr. Wu Chen selected for the 2017 American Epilepsy Society's Young Investigator Award.

More

CDC finds an increase in epilepsy among Americans

08/16/2017

“Number of Americans with active epilepsy is increasing,” concludes a national and state-specific study that was published last week in the Center for Disease Control and Prevention (CDC)’s

More